Skip to main content
Clinical Trials/ACTRN12621001634864
ACTRN12621001634864Recruiting未知

EVOLVE: Evaluation of Oedema and Lymphatic Function following Volumetric Modulated Arc Therapy for Non-melanoma Extensive Skin Field Cancerisation of the Lower Limbs

Cancer Care Research Pty Limited0 sites10 target enrollmentStarted: November 29, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
50 Years to o limit (—)
Sex
All

Inclusion Criteria

  • 1.Be aged 50 years or older
  • 2.Have symptomatic extensive skin field cancerisation (ESFC) greater than 50cm2
  • 3.Be undergoing wide field (>50cm2), VMAT radiation therapy to the lower limb at
  • GenesisCare trial sites in NSW.
  • 4.Understand and have provide written informed consent for participation in this trial.

Exclusion Criteria

  • 1.Have received prior VMAT wide field radiotherapy (>50cm2 ) to either leg.
  • 2.History of lymphoedema in either lower limb
  • 3.Lower limb peripheral vascular intervention prior to radiation therapy
  • 4.Cardiac pacemaker or Implantable Cardioverter Defibrillator (ICD)
  • 5.Allergy to shellfish or iodine
  • 6.Any other condition/factor as defined by the investigator which significantly impact the
  • patient’s involvement and suitability in this study

Investigators

Sponsor
Cancer Care Research Pty Limited

Similar Trials